finance.yahoo.com
RetiSpec Receives Award from Alzheimer's Drug Discovery Foundation to Accelerate Commercialization of Retinal Imaging Technology for Early Detection of Alzheimer's Disease
TORONTO , Oct. 8, 2019 /PRNewswire/ -- RetiSpec Inc. announced today it has received an award from the Alzheimer's Drug Discovery Foundation (ADDF) to fund the accelerated development of retinal imaging technology for the early detection of Alzheimer's disease. The award of up to USD $500,000